Gut bacteria pill joins forces with chemo to fight aggressive breast cancer
NCT ID NCT07552181
First seen Apr 29, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tests whether adding a live bacteria pill (MO-03) to standard chemotherapy and immunotherapy can improve outcomes for people with early-stage triple-negative breast cancer. About 50 participants will take the pill twice daily until surgery. The main goal is to see if the cancer disappears completely by the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CS Cancer at Valley Oncology Medical Group
Tarzana, California, 91356, United States
Contact
Contact
Contact
-
Cedars-Sinai Medical Center Beverly Hills
Beverly Hills, California, 90211, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Hunt Cancer Institute, an Affiliate of CS Cancer
Torrance, California, 90505, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.